Tirz

OVERVIEW

TIRZ is a research peptide used in preclinical laboratory models involving metabolic, mitochondrial, immune, or regenerative pathways.

What is Tirz?

Tirz, often informally referred to in research settings as GLP-2, is a synthetic peptide supplied exclusively for laboratory research use. It is classified as a dual-receptor agonist studied for its interaction with both the glucagon-like peptide-1 (GLP-1) receptor and the glucose-dependent insulinotropic polypeptide (GIP) receptor.

This dual-receptor profile distinguishes Tirz from earlier single-pathway GLP-1 research compounds and allows investigation across multiple hormonal signaling pathways associated with metabolic and endocrine regulation.

In preclinical research models, Tirz has been examined for its engagement with incretin-related signaling pathways. GLP-1 and GIP are endogenously produced peptides released in response to nutrient exposure and are commonly studied for their roles in insulin signaling, glucagon modulation, gastric motility signaling, and appetite-related regulatory mechanisms.

Tirz is supplied as a high-purity, lyophilized research peptide intended for handling and reconstitution under controlled laboratory conditions only.

MECHANISM OF INTEREST

KEY RESEARCH APPLICATIONS

- Tissue repair and regeneration research

- Inflammation pathway modeling

- Angiogenesis studies

SPECIFICATIONS

HANDLING & STORAGE

Lyophilized: Store at –20°C, protect from light and moisture.

Reconstituted: Store at 2–8°C, avoid freeze–thaw cycles.

RESEARCH USE ONLY

This product is supplied strictly for laboratory, research, and development use. Not for human consumption or therapeutic application.